Mark S. Eberhardt
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Diabetes Management and Research 8
- Diabetes Management and Education 3
- Nephrology 11
- Chronic Kidney Disease and Diabetes 9
- Co-authors
- Catherine C. Cowie (9 shared papers)Katherine M. Flegal (9 shared papers)Danita D. Byrd-Holt (4 shared papers)Maureen I Harris (5 shared papers)Sharon Saydah (11 shared papers)Randie R. Little (2 shared papers)Hsiao-Mei Wiedmeyer (2 shared papers)David E. Goldstein (2 shared papers)
- Journals
- Diabetes Care (14 papers)American Journal of Kidney Diseases (7 papers)Diabetes (3 papers)American Journal of Epidemiology (2 papers)Diabetes Research and Clinical Practice (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Mark S. Eberhardt
76 papers receiving 11.6k citations
Mark S. Eberhardt's Hit Papers
Peers
Comparison fields: 5 of 176
- Endocrinology, Diabetes and Metabolism 3.8k
- Nephrology 1.4k
- Pharmacy 345
- Epidemiology 1.5k
- Physiology 1.1k
Countries citing papers authored by Mark S. Eberhardt
This map shows the geographic impact of Mark S. Eberhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Eberhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Eberhardt more than expected).
Fields of papers citing papers by Mark S. Eberhardt
This network shows the impact of papers produced by Mark S. Eberhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Eberhardt. The network helps show where Mark S. Eberhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Eberhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Hit paper breakdown → | 1998 | 2285 |
| 2 | Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population Hit paper breakdown → | 2006 | 1050 |
| 3 | Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006 Hit paper breakdown → | 2008 | 963 |
| 4 | Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994 Hit paper breakdown → | 2013 | 680 |
| 5 | Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Hit paper breakdown → | 1999 | 557 |
| 6 | 2004 | 513 | |
| 7 | Prevalence of Lower-Extremity Disease in the U.S. Adult Population ≥40 Years of Age With and Without Diabetes Hit paper breakdown → | 2004 | 491 |
| 8 | Trends in Prevalence of Chronic Kidney Disease in the United States Hit paper breakdown → | 2016 | 488 |
| 9 | 2002 | 365 | |
| 10 | 2000 | 330 | |
| 11 | 2010 | 322 | |
| 12 | 2003 | 322 | |
| 13 | 2015 | 311 | |
| 14 | Health, United States, 2001; with Urban and rural health chartbook | 2001 | 298 |
| 15 | 2002 | 250 | |
| 16 | 2006 | 211 | |
| 17 | 1997 | 202 | |
| 18 | 2001 | 194 | |
| 19 | 2009 | 177 | |
| 20 | 2002 | 152 |
About Mark S. Eberhardt
Mark S. Eberhardt is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Genetics, Surgery and Obstetrics and Gynecology, having authored 76 papers that have together received 12.3k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Diabetes and associated disorders (13 papers), Chronic Kidney Disease and Diabetes (9 papers), Diabetes Management and Research (8 papers), Pancreatic function and diabetes (6 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Diabetes Management and Education (3 papers) and Gestational Diabetes Research and Management (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.8k citations), Nephrology (1.4k citations), Pharmacy (345 citations), Epidemiology (1.5k citations) and Physiology (1.1k citations). Mark S. Eberhardt has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Catherine C. Cowie, Katherine M. Flegal, Danita D. Byrd-Holt, Maureen I Harris, Sharon Saydah, Randie R. Little, Hsiao-Mei Wiedmeyer, David E. Goldstein, Elsie R. Pamuk and Linda S. Geiss. Their work appears in journals such as Diabetes Care, American Journal of Kidney Diseases, Diabetes, American Journal of Epidemiology and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.